Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial

BACKGROUND: Numerous worldwide clinical trials have proven the indisputably negative influence of morphine on the pharmacokinetics and pharmacodynamics of P2Y(12) receptor inhibitors in patients presenting with acute coronary syndromes. The aim of this trial was to evaluate whether oral co-administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Niezgoda, Piotr, Barańska, Malwina A., Sikora, Joanna, Sobczak, Przemysław, Buszko, Katarzyna, Sikora, Adam, Marszałł, Michał P., Navarese, Eliano P., Jilma, Bernd, Kubica, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170314/
https://www.ncbi.nlm.nih.gov/pubmed/32207836
http://dx.doi.org/10.5603/CJ.a2020.0040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170314/
https://www.ncbi.nlm.nih.gov/pubmed/32207836
http://dx.doi.org/10.5603/CJ.a2020.0040

Ejemplares similares